Document Detail

Sensitive antiproliferative neutralization assay for the detection of neutralizing IFN-alpha and IFN-beta antibodies.
MedLine Citation:
PMID:  8176238     Owner:  NLM     Status:  MEDLINE    
Antibodies to interferon (IFN) may compromise IFN treatment in some patients. In tumor therapy, a critical function of type I IFNs is their antiproliferative effect. For the quantification of neutralizing IFN antibodies we have developed an antiproliferative neutralization assay (APA) based on the reduction of IFN-mediated growth inhibition of Daudi cells by IFN-alpha and IFN-beta antibodies. Proliferation was quantified by [3H]thymidine incorporation, and the neutralizing potency of IFN antibody-positive sera was expressed as the neutralizing titer inhibiting 50% of the antiproliferative activity of 10 IU/ml of IFN (NT50). The APA is easy to perform, reproducible, and more sensitive than a well-established antiviral neutralization assay (AVA). All 30 sera with recombinant IFN-alpha 2a-binding antibodies proved to be neutralizing antibody-positive in the APA whereas seven were scored antibody-negative or uninterpretable in the AVA. The APA is recommended as a second or third line assay for the estimation of the neutralizing potency of spontaneous or treatment-induced IFN-alpha and IFN-beta-specific antibodies.
O Prümmer; U Streichan; H Heimpel; F Porzsolt
Related Documents :
2491828 - Inhibition of proliferation of lines derived from human cervical carcinomas by cytotoxi...
3037288 - Sensitivity in vitro of herpes simplex virus isolates to human fibroblast interferon.
18683548 - Use of oromucosally administered interferon-alpha in the prevention and treatment of an...
2659728 - Differential expression of interferon alpha and beta induced with newcastle disease vir...
22215228 - In vivo efficacy and pharmacokinetics of biapenem in a murine model of ventilator-assoc...
7957928 - Synergistic activation of intercellular adhesion molecule 1 (icam-1) by tnf-alpha and i...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Journal of immunological methods     Volume:  171     ISSN:  0022-1759     ISO Abbreviation:  J. Immunol. Methods     Publication Date:  1994 May 
Date Detail:
Created Date:  1994-06-08     Completed Date:  1994-06-08     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  1305440     Medline TA:  J Immunol Methods     Country:  NETHERLANDS    
Other Details:
Languages:  eng     Pagination:  45-53     Citation Subset:  IM    
Department of Medicine III, University of Ulm, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Antibodies / blood*,  immunology
Antibody Specificity
Cell Division / drug effects
Interferon Type I, Recombinant / antagonists & inhibitors*,  immunology,  pharmacology
Interferon-beta / antagonists & inhibitors*,  immunology,  pharmacology
Neutralization Tests / methods*
Pilot Projects
Reproducibility of Results
Sensitivity and Specificity
Reg. No./Substance:
0/Antibodies; 0/Interferon Type I, Recombinant; 77238-31-4/Interferon-beta

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  A technique for complete thymectomy in adult rats.
Next Document:  Efficient in vivo induction of CTL by cell-associated covalent H-2Kd-peptide complexes.